AJP - Renal Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 291: F384-F394, 2006. First published March 28, 2006; doi:10.1152/ajprenal.00418.2005
0363-6127/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/2/F384    most recent
00418.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sinuani, I.
Right arrow Articles by Weissgarten, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sinuani, I.
Right arrow Articles by Weissgarten, J.

Mesangial cells initiate compensatory renal tubular hypertrophy via IL-10-induced TGF-beta secretion: effect of the immunomodulator AS101 on this process

Inna Sinuani,1,2,* Zhan Averbukh,1,* Inna Gitelman,3 Micha J. Rapoport,4 Judit Sandbank,5 Michael Albeck,6 Benjamin Sredni,2,* and Joshua Weissgarten1,*

1Nephrology Division, Assaf Harofeh Medical Center, Zerifin; 2C.A.I.R. Institute, Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan; 3Department of Molecular Genetics of Development, Ben Gurion University, Beer Sheva; 4Department of Internal Medicine C, Assaf Harofeh Medical Center, Zerifin; 5Department of Pathology, Assaf Harofeh Medical Center, Zerifin; and 6Department of Chemistry, Faculty of Exact Sciences, Bar-Ilan University, Ramat Gan, Israel

Submitted 23 October 2005 ; accepted in final form 8 March 2006

The present study investigated the role of IL-10 produced by the mesangial cells in postnephrectomy compensatory renal growth and the effect of the immunomodulator AS101 on this process. One hundred forty unilateral nephrectomized and sham-operated male Sprague-Dawley rats were treated by AS101 or PBS before and after surgery. The results show that secretion of IL-10 and TGF-beta by mesangial cells isolated from the remaining kidneys was increased significantly, compared with those of control and sham animals. Moreover, TGF-beta secretion by mesangial cells was increased after the addition of exogenous recombinant IL-10 and inhibited in the presence of neutralizing anti-IL-10 antibodies. In vivo, compensatory growth of the remaining kidneys was associated with significant increase in IL-10 content in renal tissues and plasma. Immunohistochemical studies show that IL-10 was produced by mesangial cells. Elevated IL-10 levels were followed by the rise in TGF-beta content in plasma and renal tissue. AS101 treatment decreased IL-10 and TGF-beta expression in plasma and kidney tissues and results in 25% reduction in the fresh and fractional kidney weight and decreased hypertrophy of tubular cells (protein/DNA ratio, morphometric analysis). Taken together, these data demonstrate that TGF-beta production by mesangial cells is IL-10 dependent. Mesangial cells are the major source of IL-10 in kidneys. AS101, by inhibiting the activity of IL-10, decreases TGF-beta production by mesangial cells, thus limiting compensatory tubular cell hypertrophy.

unilateral nephrectomy; cytokines; tubular cells



Address for reprint requests and other correspondence: Z. Averbukh, Nephrology Division, Assaf Harofeh Medical Center, 70300 Zerifin, Israel (e-mail: averbukhzh{at}asaf.health.gov.il)




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
B. S. Kasinath, D. Feliers, K. Sataranatarajan, G. Ghosh Choudhury, M. J. Lee, and M. M. Mariappan
Regulation of mRNA translation in renal physiology and disease
Am J Physiol Renal Physiol, November 1, 2009; 297(5): F1153 - F1165.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
I. Sinuani, J. Weissgarten, I. Beberashvili, M. J. Rapoport, J. Sandbank, L. Feldman, M. Albeck, Z. Averbukh, and B. Sredni
The cyclin kinase inhibitor p57kip2 regulates TGF-{beta}-induced compensatory tubular hypertrophy: effect of the immunomodulator AS101
Nephrol. Dial. Transplant., August 1, 2009; 24(8): 2328 - 2338.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Carmely, D. Meirow, A. Peretz, M. Albeck, B. Bartoov, and B. Sredni
Protective effect of the immunomodulator AS101 against cyclophosphamide-induced testicular damage in mice
Hum. Reprod., June 1, 2009; 24(6): 1322 - 1329.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
W. Wang, W. Brian Reeves, and G. Ramesh
Netrin-1 and kidney injury. I. Netrin-1 protects against ischemia-reperfusion injury of the kidney
Am J Physiol Renal Physiol, April 1, 2008; 294(4): F739 - F747.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
E. S. Jeon, H. J. Moon, M. J. Lee, H. Y. Song, Y. M. Kim, Y. C. Bae, J. S. Jung, and J. H. Kim
Sphingosylphosphorylcholine induces differentiation of human mesenchymal stem cells into smooth-muscle-like cells through a TGF-{beta}-dependent mechanism
J. Cell Sci., December 1, 2006; 119(23): 4994 - 5005.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.